RJA
INVA icon

Raymond James & Associates’s Innoviva INVA Stock Holding History

Raymond James & Associates’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,549
Closed -$223K – 4115
2022
Q1 		$223K Sell
11,549
-1,967
-15% -$35.1K ﹤0.01% 3610
2021
Q4 		$233K Buy
+13,516
New +$230K ﹤0.01% 3599
2018
Q2 		– Sell
-19,900
Closed -$332K – 3631
2018
Q1 		$332K Buy
+19,900
New +$307K ﹤0.01% 2826
2017
Q2 		– Sell
-11,546
Closed -$160K – 3383
2017
Q1 		$160K Buy
+11,546
New +$136K ﹤0.01% 2985
2015
Q1 		– Sell
-39,925
Closed -$565K – 2365
2014
Q4 		$565K Buy
+39,925
New +$600K ﹤0.01% 1885
2014
Q1 		– Sell
-15,227
Closed -$437K – 2101
2013
Q4 		$437K Sell
15,227
-2,749
-15% -$80.4K ﹤0.01% 1724
2013
Q3 		$592K Sell
17,976
-8,346
-32% -$260K 0.01% 1519
2013
Q2 		$817K Buy
+26,322
New +$706K 0.01% 1268

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Raymond James & Associates's INVA Position: Q2 2022 in Review

Raymond James & Associates sold out of Innoviva (INVA) in Q2 2022, closing a stake of 11,549 shares — an estimated $223K sold.

Raymond James & Associates first reported a position in INVA in Q2 2013 and held it in 8 quarters. The position peaked at $817K in Q2 2013. 218 funds tracked by Wall St. Rank hold INVA as of Q2 2022.

  • Raymond James & Associates reported no remaining Innoviva position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 11,549 Innoviva shares in Q2 2022, an estimated $223K.
  • Raymond James & Associates first reported a position in Innoviva in Q2 2013 and held it in 8 quarters.
  • Raymond James & Associates's Innoviva position peaked at $817K in Q2 2013.
  • 218 funds tracked by Wall St. Rank held Innoviva as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.